Open Access
Issue
OCL
Volume 21, Number 3, May-June 2014
Article Number D307
Number of page(s) 4
Section Dossier: Vitamin D, vitamin or hormone? / La vitamine D, vitamine ou hormone ?
DOI https://doi.org/10.1051/ocl/2013057
Published online 29 April 2014
  • Afzal S, Bojesen SE, Nordestgaard BG. 2013. Reduced 25-hydroxyvitamin D and risk of Alzheimer’s disease and vascular dementia. Alzheimers Dement. DOI: 10.1016/j.jalz.2013. 05.1765. [Google Scholar]
  • Annweiler C, Beauchet O. 2011. Vitamin D-mentia: randomized clinical trials should be the next step. Neuroepidemiology 37: 249–258. [CrossRef] [PubMed] [Google Scholar]
  • Annweiler C, Beauchet O. 2012. Possibility of a new anti-alzheimer’s disease pharmaceutical composition combining memantine and vitamin D. Drugs Aging 29: 81–91. [CrossRef] [PubMed] [Google Scholar]
  • Annweiler C, Beauchet O. 2013. Vitamin D and cognition: recommendations for future trials. J. Am. Geriatr. Soc. 61: 1049–1050. [CrossRef] [PubMed] [Google Scholar]
  • Annweiler C, Allali G, Allain P, et al. 2009. Vitamin D and cognitive performance in adults: a systematic review. Eur. J. Neurol. 16: 1083–1089. [CrossRef] [PubMed] [Google Scholar]
  • Annweiler C, Le Gall D, Fantino B, Beauchet O, Tucker KL, Buell JS. 2010. 25-hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology 75: 95. [CrossRef] [PubMed] [Google Scholar]
  • Annweiler C, Schott AM, Allali G, et al. 2010. Association of vitamin D deficiency with cognitive impairment in older women: cross-sectional study. Neurology 74: 27–32. [CrossRef] [PubMed] [Google Scholar]
  • Annweiler C, Schott AM, Berrut G, Chauviré V, Le Gall D, Inzitari M, Beauchet O. 2010. Vitamin D and ageing: neurological issues. Neuropsychobiology 62: 139–150. [CrossRef] [PubMed] [Google Scholar]
  • Annweiler C, Schott AM, Rolland Y, Blain H, Herrmann FR, Beauchet O. 2010. Dietary intake of vitamin D and cognition in older women: a large population-based study. Neurology 75: 1810–1816. [CrossRef] [PubMed] [Google Scholar]
  • Annweiler C, Fantino B, Le Gall D, Schott AM, Berrut G, Beauchet O. 2011. Severe vitamin D deficiency is associated with advanced-stage dementia in geriatric inpatients. J. Am. Geriatr. Soc. 59: 169–171. [CrossRef] [PubMed] [Google Scholar]
  • Annweiler C, Rolland Y, Schott AM, Blain H, Vellas B, Beauchet O. 2011. Serum vitamin D deficiency as a predictor of incident non-Alzheimer dementias: a 7-year longitudinal study. Dement. Geriatr. Cogn. Disord. 32: 273–278. [CrossRef] [PubMed] [Google Scholar]
  • Annweiler C, Souberbielle JC, Schott AM, de Decker L, Berrut G, Beauchet O. 2011. Vitamin D in the elderly: 5 points to remember. Geriatr. Psychol. Neuropsych. Vieil. 9: 259–267. [Google Scholar]
  • Annweiler C, Fantino B, Gautier J, Beaudenon M, Thiery S, Beauchet O. 2012. Cognitive effects of vitamin D supplementation in older outpatients visiting a memory clinic: a pre-post study. J. Am. Geriatr. Soc. 60: 793–795. [CrossRef] [PubMed] [Google Scholar]
  • Annweiler C, Herrmann FR, Fantino B, Brugg B, Beauchet O. 2012. Effectiveness of the combination of memantine plus vitamin D on cognition in patients with Alzheimer disease: a pre-post pilot study. Cogn. Behav. Neurol. 25: 121–127. [CrossRef] [PubMed] [Google Scholar]
  • Annweiler C, Rolland Y, Schott AM, Blain H, Vellas B, Herrmann FR, Beauchet O. 2012. Higher vitamin D dietary intake is associated with lower risk of Alzheimer’s disease: a 7-year follow-up. J. Gerontol. A Biol. Sci. Med. Sci. 67: 1205–1211. [CrossRef] [PubMed] [Google Scholar]
  • Annweiler C, Llewellyn DJ, Beauchet O. 2013. Low serum vitamin D concentrations in Alzheimer’s disease: a systematic review and meta-analysis. J. Alzheimers Dis. 33: 659–674. [PubMed] [Google Scholar]
  • Annweiler C, Montero-Odasso M, Hachinski V, Seshadri S, Bartha R, Beauchet O. 2013. Vitamin D concentration and lateral cerebral ventricle volume in older adults. Mol. Nutr. Food Res. 57: 267–276. [CrossRef] [PubMed] [Google Scholar]
  • Annweiler C, Montero-Odasso M, Llewellyn DJ, Richard-Devantoy S, Duque G, Beauchet O. 2013. Meta-analysis of memory and executive dysfunctions in relation to vitamin D. J. Alzheimers Dis. 37: 147–171. [PubMed] [Google Scholar]
  • Annweiler C, Brugg B, Peyrin JM, Bartha R, Beauchet O. 2014. Combination of memantine and vitamin D prevents axon degeneration induced by amyloid-beta and glutamate. Neurobiol. Aging 35: 331–335. [CrossRef] [PubMed] [Google Scholar]
  • Brewer LD, Thibault V, Chen KC, Langub MC, Landfield PW, Porter NM. 2001. Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. J. Neurosci. 21: 98–108. [PubMed] [Google Scholar]
  • Brown J, Bianco JI, McGrath JJ, Eyles DW. 2003. 1,25-Dihydroxyvitamin D-3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci. Lett. 343: 139–143. [CrossRef] [PubMed] [Google Scholar]
  • Buell JS, Dawson-Hughes B, Scott TM, et al. 2010. 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology 74: 18–26. [CrossRef] [PubMed] [Google Scholar]
  • Cavalli A, Bolognesi ML, Minarini A, et al. 2008. Multi-target-directed ligands to combat neurodegenerative diseases. J. Med. Chem. 51: 347–372. [CrossRef] [PubMed] [Google Scholar]
  • Etgen T, Sander D, Bickel H, Sander K, Förstl H. 2012. Vitamin D deficiency, cognitive impairment and dementia: a systematic review and meta-analysis. Dement. Geriatr. Cogn. Disord. 33: 297–305. [CrossRef] [PubMed] [Google Scholar]
  • Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D. 2002. New clues about vitamin D functions in the nervous system. Trends Endocrinol. Metab. 13: 100–105. [CrossRef] [PubMed] [Google Scholar]
  • Holick MF. 2007. Vitamin D deficiency. N. Engl. J. Med. 357: 266–281. [CrossRef] [PubMed] [Google Scholar]
  • Ibi M, Sawada H, Nakanishi M, et al. 2001. Protective effects of 1 alpha,25-(OH)(2)D(3) against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture. Neuropharmacology 40: 761–771. [CrossRef] [PubMed] [Google Scholar]
  • Ito S, Ohtsuki S, Nezu Y, Koitabashi Y, Murata S, Terasaki T. 2011. 1α, 25-Dihydroxyvitamin D3 enhances cerebral clearance of human amyloid-β peptide (1–40) from mouse brain across the blood-brain barrier. Fluids Barriers CNS 8: 20. [CrossRef] [PubMed] [Google Scholar]
  • Kalueff AV, Tuohimaa P. 2007. Neurosteroid hormone vitamin D and its utility in clinical nutrition. Curr. Opin. Clin. Nutr. Metab. Care 10: 12–19. [CrossRef] [PubMed] [Google Scholar]
  • Llewellyn DJ, Lang IA, Langa KM, et al. 2010. Vitamin D and risk of cognitive decline in elderly persons. Arch. Intern. Med. 170: 1135–1141. [CrossRef] [PubMed] [Google Scholar]
  • Moore ME, Piazza A, McCartney Y, Lynch MA. 2005. Evidence that vitamin D3 reverses age-related inflammatory changes in the rat hippocampus. Biochem. Soc. Trans. 33: 573–577. [CrossRef] [PubMed] [Google Scholar]
  • Masoumi A, Goldenson B, Ghirmai S, et al. 2009. 1Alpha,25-dihydroxyvitamin D3 interacts with curcuminoids to stimulate amyloid-beta clearance by macrophages of Alzheimer’s disease patients. J. Alzheimers Dis. 17: 703–717. [PubMed] [Google Scholar]
  • Prybelski R, Agrawal S, Krueger D, Engelke JA, Walbrun F, Binkley N. 2008. Rapid correction of low vitamin D status in nursing home residents. Osteoporos. Int. 19: 1621–1628. [CrossRef] [PubMed] [Google Scholar]
  • Slinin Y, Paudel ML, Taylor BC, et al. 2010. Osteoporotic Fractures in Men (MrOS) Study Research Group. 25-Hydroxyvitamin D levels and cognitive performance and decline in elderly men. Neurology 74: 33–41. [CrossRef] [PubMed] [Google Scholar]
  • Slinin Y, Paudel M, Taylor BC, et al. 2012. Study of Osteoporotic Fractures Research Group. Association between serum 25(OH) vitamin D and the risk of cognitive decline in older women. J. Gerontol. A Biol. Sci. Med. Sci. 67: 1092–1098. [CrossRef] [PubMed] [Google Scholar]
  • Stein MS, Scherer SC, Ladd KS, Harrison LC. 2011. A randomized controlled trial of high-dose vitamin D2 followed by intranasal insulin in Alzheimer’s disease. J. Alzheimers Dis. 26: 477–484. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.